Learn more about our Advocacy work.
In a letter to President Joe Biden today, AdvaMed® President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances…
Today, the Advanced Medical Technology Association® (AdvaMed®) responded to the Department of Commerce following the release of a report on a recent request for information on the semiconductor supply chain.…
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed®’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the…
Today, the Advanced Medical Technology Association® (AdvaMed®) released the following statement from President and CEO Scott Whitaker regarding the White House’s newest measures to address the COVID-19 pandemic and rising…
AdvaMed® released the following statement from President and CEO Scott Whitaker on the Administration’s announcement today that, (1) beginning in January, private insurance plans will cover the cost of at-home…
Today, the Advanced Medical Technology Association® (AdvaMed®) released the following statement from President and CEO Scott Whitaker on the introduction by U.S. Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.)…
AdvaMed®, the world’s largest trade organization representing medical technology companies, released the following statements on President Joe Biden’s nomination of Dr. Robert Califf to serve again as Commissioner of the Food and…
Today, the Advanced Medical Technology Association® (AdvaMed®) released the following statement from President and CEO Scott Whitaker regarding the Centers for Medicare and Medicaid Services (CMS) recission of the Medicare…
Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.
Today, the Advanced Medical Technology Association® (AdvaMed®) submitted a response to the Department of Commerce’s request for comments on the risks in the semiconductor supply chain.